1 Prescription Drugs Market Overview
1.1 Product Overview and Scope of Prescription Drugs
1.2 Prescription Drugs Segment by Type
1.2.1 Global Prescription Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Brand Drugs
1.2.3 Generic Drug
1.3 Prescription Drugs Segment by Application
1.3.1 Global Prescription Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Prescription Drugs Market Size Estimates and Forecasts
1.4.1 Global Prescription Drugs Revenue 2017-2028
1.4.2 Global Prescription Drugs Sales 2017-2028
1.4.3 Prescription Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Prescription Drugs Market Competition by Manufacturers
2.1 Global Prescription Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Prescription Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Prescription Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Prescription Drugs Manufacturing Sites, Area Served, Product Type
2.5 Prescription Drugs Market Competitive Situation and Trends
2.5.1 Prescription Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Prescription Drugs Players Market Share by Revenue
2.5.3 Global Prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prescription Drugs Retrospective Market Scenario by Region
3.1 Global Prescription Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Prescription Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Prescription Drugs Market Facts & Figures by Country
3.3.1 North America Prescription Drugs Sales by Country
3.3.2 North America Prescription Drugs Revenue by Country
3.3.3 the United States
3.3.4 Canada
3.4 Europe Prescription Drugs Market Facts & Figures by Country
3.4.1 Europe Prescription Drugs Sales by Country
3.4.2 Europe Prescription Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Prescription Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Prescription Drugs Sales by Region
3.5.2 Asia Pacific Prescription Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Prescription Drugs Market Facts & Figures by Country
3.6.1 Latin America Prescription Drugs Sales by Country
3.6.2 Latin America Prescription Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Prescription Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Prescription Drugs Sales by Country
3.7.2 Middle East and Africa Prescription Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Prescription Drugs Historic Market Analysis by Type
4.1 Global Prescription Drugs Sales Market Share by Type (2017-2022)
4.2 Global Prescription Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Prescription Drugs Price by Type (2017-2022)
5 Global Prescription Drugs Historic Market Analysis by Application
5.1 Global Prescription Drugs Sales Market Share by Application (2017-2022)
5.2 Global Prescription Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Prescription Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer Prescription Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Roche Prescription Drugs Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Sanofi Prescription Drugs Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Johnson & Johnson Prescription Drugs Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Merck & Co. (MSD)
6.5.1 Merck & Co. (MSD) Corporation Information
6.5.2 Merck & Co. (MSD) Description and Business Overview
6.5.3 Merck & Co. (MSD) Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Merck & Co. (MSD) Prescription Drugs Product Portfolio
6.5.5 Merck & Co. (MSD) Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Novartis Prescription Drugs Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 AbbVie
6.6.1 AbbVie Corporation Information
6.6.2 AbbVie Description and Business Overview
6.6.3 AbbVie Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 AbbVie Prescription Drugs Product Portfolio
6.7.5 AbbVie Recent Developments/Updates
6.8 Gilead Sciences
6.8.1 Gilead Sciences Corporation Information
6.8.2 Gilead Sciences Description and Business Overview
6.8.3 Gilead Sciences Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Gilead Sciences Prescription Drugs Product Portfolio
6.8.5 Gilead Sciences Recent Developments/Updates
6.9 GlaxoSmithKline (GSK)
6.9.1 GlaxoSmithKline (GSK) Corporation Information
6.9.2 GlaxoSmithKline (GSK) Description and Business Overview
6.9.3 GlaxoSmithKline (GSK) Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 GlaxoSmithKline (GSK) Prescription Drugs Product Portfolio
6.9.5 GlaxoSmithKline (GSK) Recent Developments/Updates
6.10 Amgen
6.10.1 Amgen Corporation Information
6.10.2 Amgen Description and Business Overview
6.10.3 Amgen Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Amgen Prescription Drugs Product Portfolio
6.10.5 Amgen Recent Developments/Updates
6.11 AstraZeneca
6.11.1 AstraZeneca Corporation Information
6.11.2 AstraZeneca Prescription Drugs Description and Business Overview
6.11.3 AstraZeneca Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 AstraZeneca Prescription Drugs Product Portfolio
6.11.5 AstraZeneca Recent Developments/Updates
6.12 Bristol-Myers Squibb
6.12.1 Bristol-Myers Squibb Corporation Information
6.12.2 Bristol-Myers Squibb Prescription Drugs Description and Business Overview
6.12.3 Bristol-Myers Squibb Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Bristol-Myers Squibb Prescription Drugs Product Portfolio
6.12.5 Bristol-Myers Squibb Recent Developments/Updates
6.13 Eli Lilly
6.13.1 Eli Lilly Corporation Information
6.13.2 Eli Lilly Prescription Drugs Description and Business Overview
6.13.3 Eli Lilly Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Eli Lilly Prescription Drugs Product Portfolio
6.13.5 Eli Lilly Recent Developments/Updates
6.14 Teva
6.14.1 Teva Corporation Information
6.14.2 Teva Prescription Drugs Description and Business Overview
6.14.3 Teva Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Teva Prescription Drugs Product Portfolio
6.14.5 Teva Recent Developments/Updates
6.15 Bayer
6.15.1 Bayer Corporation Information
6.15.2 Bayer Prescription Drugs Description and Business Overview
6.15.3 Bayer Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Bayer Prescription Drugs Product Portfolio
6.15.5 Bayer Recent Developments/Updates
6.16 Novo Nordisk
6.16.1 Novo Nordisk Corporation Information
6.16.2 Novo Nordisk Prescription Drugs Description and Business Overview
6.16.3 Novo Nordisk Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Novo Nordisk Prescription Drugs Product Portfolio
6.16.5 Novo Nordisk Recent Developments/Updates
6.17 Allergan
6.17.1 Allergan Corporation Information
6.17.2 Allergan Prescription Drugs Description and Business Overview
6.17.3 Allergan Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Allergan Prescription Drugs Product Portfolio
6.17.5 Allergan Recent Developments/Updates
6.18 Takeda
6.18.1 Takeda Corporation Information
6.18.2 Takeda Prescription Drugs Description and Business Overview
6.18.3 Takeda Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Takeda Prescription Drugs Product Portfolio
6.18.5 Takeda Recent Developments/Updates
6.19 Boehringer Ingelheim
6.19.1 Boehringer Ingelheim Corporation Information
6.19.2 Boehringer Ingelheim Prescription Drugs Description and Business Overview
6.19.3 Boehringer Ingelheim Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Boehringer Ingelheim Prescription Drugs Product Portfolio
6.19.5 Boehringer Ingelheim Recent Developments/Updates
6.20 Takeda
6.20.1 Takeda Corporation Information
6.20.2 Takeda Prescription Drugs Description and Business Overview
6.20.3 Takeda Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Takeda Prescription Drugs Product Portfolio
6.20.5 Takeda Recent Developments/Updates
7 Prescription Drugs Manufacturing Cost Analysis
7.1 Prescription Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Prescription Drugs
7.4 Prescription Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Prescription Drugs Distributors List
8.3 Prescription Drugs Customers
9 Prescription Drugs Market Dynamics
9.1 Prescription Drugs Industry Trends
9.2 Prescription Drugs Market Drivers
9.3 Prescription Drugs Market Challenges
9.4 Prescription Drugs Market Restraints
10 Global Market Forecast
10.1 Prescription Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Prescription Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Prescription Drugs by Type (2023-2028)
10.2 Prescription Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Prescription Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Prescription Drugs by Application (2023-2028)
10.3 Prescription Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Prescription Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Prescription Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
